The FMR2 gene, FRAXE and non-specific X-linked mental retardation: Clinical and molecular aspects

Annals of Human Genetics

Volumn 64, Issue 2, 2000, Pages 95-106

  Gecz, J ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

REPETITIVE DNA; TRINUCLEOTIDE;

CLINICAL FEATURE; FRAGILE X SYNDROME; GENE; GENE MAPPING; GENE MUTATION; HUMAN; MENTAL DEFICIENCY; PRIORITY JOURNAL; REVIEW; TRINUCLEOTIDE REPEAT; X CHROMOSOME LINKAGE;

CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; FRAGILE X SYNDROME; GENETIC SCREENING; HUMANS; LINKAGE (GENETICS); MALE; MENTAL RETARDATION; MUTATION; NUCLEAR PROTEINS; PHENOTYPE; PROTEINS; TRANS-ACTIVATORS; X CHROMOSOME;

EID: 0033915841     PISSN: 00034800     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0003480000007983     Document Type: Review

References (85)

1. Abrams, M. T., Doheny, K. F., Mazzocco, M. M., Knight, S. J., Baumgardner, T. L., Freund, L. S., Davies, K. E. & Reiss, A. L. (1997) Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE. Am. J. Med. Genet. 74, 73-81.
2. Allen, K. M., Gleeson, J. G., Bagrodia, S., Partington, M. W., Macmillan, J. C. Cerione, R. A., Mulley, J. C. & Walsh, C. A. (1998). PAK3 mutation in nonsyndromic X-linked mental retardation. Nature Genet. 20, 25-30.
3. Allingham-Hawkins, D. J. & Ray, P. N. (1995). FRAXE expansion is not a common etiological factor among developmentally delayed males. Am. J. Hum. Genet. 57, 72-76.
4. Antonarakis, S. E. & Van Aelst, L. (1998). Mind the GAP, Rho, Rab and GDI. Nat. Genet. 19, 106-108.
5. Biancalana, V., Taine, L., Bouix, J. C., Finck, S., Chauvin, A., Deverneuil, H., Knight, S. J. L., Stoll, C., Lacombe, D. & Mandel, J. L. (1996). Expansion and methylation status at Fraxe can be detected on Ecori blots used for Fraxa diagnosis -analysis of four Fraxe families with mild mental retardation in males. Am. J. Hum. Genet. 59, 847-854.
6. Billuart, P., Bienvenu, T., Ronce, N., Des Portes, V., Vinet, M. C., Zemni, R., Crollius, H. R., Carrie, A., Fauchereau, F., Cherry, M., Briault, S., Hamel, B., Fryns, J. P., Beldjord, C., Kahn, A., Moraine, C. & Chelly, J. (1998). Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 392, 923-926.
7. Brown, T. C., Descartes, M., Tarleton, J. & Finley, W. H. (1996). Population study and correlation analysis of FRAXA and FRAXE trinucleotide repeats. Am. J. Hum. Genet. Suppl. 59, A250 (1443).
8. Brown, T. C., Tarleton, J. C., Go, R. C., Longshore, J. W. & Descartes, M. (1997). Instability of the FMR2 trinucleotide repeat region associated with expanded FMR1 alleles. Am. J. Med. Genet. 73, 447-455.
9. Brown, W. T. (1996). The FRAXE syndrome: is it time for routine screening? Am. J. Hum. Genet. 58, 903.
10. Campbell, S. L., Khosravi-Far, R., Rossman, K. L., Clark, G. J. & Der, C. J. (1998). Increasing complexity of Ras signaling. Oncogene. 17, 1395-1413.
11. Carbonell, P., Lopez, I., Gabarron, J., Bernabe, M. J., Lucas, J. M., Guitart, M., Gabau, E. & Glover, G. (1996). FRAXE mutation analysis in three Spanish families. Am. J. Med. Genet. 64, 434-440.
12. Carrie, A., Jun, L., Bienvenu, T., Vinet, M. C., McDonell, N., Couvert, P., Zemni, R., Cardona, A., Van Buggenhout, G., Frints, S., Hamel, B., Moraine, C., Ropers, H. H., Strom, T., Howell, G. R., Whittaker, A., Ross, M. T., Kahn, A., Fryns, J. P., Beldjord, C., Marynen, P. & Chelly, J. (1999). A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nature Genet. 23, 25-31.
13. Chakrabarti, L., Bristulf, J., Foss, G. S. & Davies, K. E. (1998). Expression of the murine homologue of FMR2 in mouse brain and during development. Hum. Mol. Genet. 7, 441-448.
14. Chakrabarti, L., Knight, S. J., Flannery, A. V. & Davies, K. E. (1996). A candidate gene for mild mental handicap at the FRAXE fragile site. Hum. Mol. Genet. 5, 275-282.
15. Chan, S. Y. & Wong, V. (1998). DNA diagnosis of FRAXA and FRAXE in Chinese children with neurodevelopmental disorders and fragile X syndrome. Clin. Genet. 53, 179-183.
16. Chelly, J. (1999). Breakthroughs in molecular and cellular mechanisms underlying X-linked mental retardation. Hum. Mol. Genet. 8, 1833-1838.
17. Chen, C. H., Horng, C. J., Shyu, P. W., Liu, M. Y., Wang-Wuu, S., Wuu, K. D. & Hsiao, K. J. (1996). Identification of FRAXA and FRAXE syndromes by using a non-radioactive duplex PCR and Southern blot analysis in Chinese mentally retarded males from Taiwan. Am. J. Hum. Genet. Suppl. 59, A394 (2300).
18. Crawford, D. C., Meadows, K. L., Newman, J. L., Taft, L. F., Pettay, D. L., Gold, L. B., Hersey, S. J., Hinkle, E. F., Stanfield, M. L., Holmgreen, P., Yeargin-Allsopp, M., Boyle, C. & Sherman, S. L. (1999). Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am. J. Hum. Genet. 64, 495-507.
19. Cronister, A., Schreiner, R., Wittenberger, M., Amiri, K., Harris, K., & Hagerman, R. J. (1991). Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. Am. J. Med. Genet. 38, 269-274.
20. D'Adamo, P., Menegon, A., Lo Nigro, C., Grasso, M., Gulisano, M., Tamanini, F., Bienvenu, T., Gedeon, A. K., Oostra, B., Wu, S. K., Tandon, A., Valtorta, F., Balch, W. E., Chelly, J. & Toniolo, D. (1998). Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nature Genet. 19, 134-139.
21. De Boulle, K., Verkerk, A. J., Reyniers, E., Vits, L., Hendrickx, J., Van Roy, B., Van Den Bos, F., De Graaff, E., Oostra, B. A. & Willems, P. J. (1993). A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nature Genet. 3, 31-35.
22. De Vries, B. B., Wiegers, A. M., Smits, A. P., Mohkamsing, S., Duivenvoorden, H. J., Fryns, J. P., Curfs, L. M., Halley, D. J., Oostra, B. A., Van Den Ouweland, A. M. & Niermeijer, M. F. (1996). Mental status of females with an FMR1 gene full mutation. Am. J. Hum. Genet. 58, 1025-1032.
23. Fisch, G. S., Carpenter, N., Holden, J. J., Howard-Peebles, P. N., Maddalena, A., Borghgraef, M., Steyaert, J. & Fryns, J. P. (1999a). Longitudinal changes in cognitive and adaptive behavior in fragile X females: a prospective multicenter analysis. Am. J. Med. Genet. 83, 308-312.
24. Fisch, G. S., Carpenter, N. J., Simensen, R., Smits, A. P., Van Roosmalen, T. & Hamel, B. C. (1999b). Longitudinal changes in cognitive-behavioral levels in three children with FRAXE. Am. J. Med. Genet. 84, 291-292.
25. Flynn, G. A., Hirst, M. C., Knight, S. J., Macpherson, J. N., Barber, J. C., Flannery, A. V., Davies, K. E. & Buckle, V. J. (1993). Identitication of the FRAXE fragile site in two families ascertained for X linked mental retardation. J. Med. Genet. 30, 97-100.
26. Frestedt, J. L., Hilden, J. M. & Kersey, J. H. (1996). AF4/FEL. a gene involved in infant leukemia: sequence variations, gene structure, and possible homology with a genomic sequence on 5q31. DNA Cell. Biol. 15, 669-678.
27. Gecz, J., Barnett, S., Liu, J. Hollway, G., Donnelly, A., Eyre, H., Eshkevari, H. S., Baltazar, R., Grunn, A., Nagaraja, R., Gilliam, C., Peltonen, L., Sutherland, G. R., Baron, M. & Mulley, J. C. (1999). Characterization of the Human Glutamate Receptor Subunit 3 Gene (GRIA3), a Candidate for Bipolar Disorder and Nonspecific X-Linked Mental Retardation. Genomics 62, 356-368.
28. Gecz, J., Bielby, S., Sutherland, G. R. & Mulley, J. C. (1997a). Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. Genomics 44, 201-213.
29. Gecz, J., Oostra, B. A., Hockey, A., Carbonell, P., Turner, G., Haan, E. A., Sutherland, G. R. & Mulley, J. C. (1997b). FMR2 expression in families with FRAXE mental retardation. Hum. Mol. Genet. 6, 435-441.
30. Gecz, J., Gedeon, A. K., Sutherland, G. R. & Mulley, J. C. (1996). Identification of the gene FMR2, associated with FRAXE mental retardation. Nature Genet. 13, 105-108.
31. Gecz, J. & Mulley, J. C. (2000). Genes for cognitive function: developments on the X. Genome Res. 10, 157-163.
32. Gecz, J. & Mulley, J. C. (1999). Characterisation and expression of a large, 13.7 kb FMR2 isoform. Eur. J. Hum. Genet. 7, 157-162.
33. Gedeon, A. K., Keinanen, M., Ades, L. C., Kaariainen, H., Gecz, J., Baker, E., Sutherland, G. R. & Mulley, J. C. (1995). Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: identification of a gene near FRAXE. Am. J. Hum. Genet. 56, 907-914.
34. Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C. M. & Canaani, E. (1992). The t(4:11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71, 701-708.
35. Gu, Y., Shen, Y., Gibbs, R. A. & Nelson, D. L. (1996). Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nature Genet. 13, 109-113.
36. Hemler, M. E. (1998). Integrin associated proteins. Curr. Opin. Cell Biol. 10, 578-585.
37. Holden, J. J., Julien-Inalsingh, C., Chalifoux, M., Wing, M., Scott, E., Fidler, K., Swift, I., Maidment, B., Knight, S. J., Davies, K. E. & White, B. N. (1996a). Trinucleotide repeat expansion in the FRAXE locus is not common among institutionalized individuals with non-specific developmental disabilities. Am. J. Med. Genet. 64, 420-423.
38. Holden, J. J., Wing, M., Chalifoux, M., Julien-Inalsingh, C., Schutz, C., Robinson, P., Szatmari, P. & White, B. N. (1996b). Lack of expansion of triplet repeats in the FMR1, FRAXE, and FRAXF loci in male multiplex families with autism and pervasive developmental disorders. Am. J. Med. Genet. 64, 399-403.
39. Holinski-Feder, E., Chahrokh-Zadeh, M., Jedele, K. B., Meindl, A., Steinbach, P. & Wohrle, D. (1996). FRAXE testing. Am. J. Hum. Genet. 59, 1168-1169.
40. Kerr, B., Turner, C., Mulley, J. C., Gedeon, A. & Partington, M. (1991). Non-specific X linked mental retardation. J. Med. Genet. 28, 378-382.
41. Knight, S. J., Flannery, A. V., Hirst, M. C., Campbell, L., Christodoulou, Z., Phelps, S. R., Pointon, J., Middleton Price, H. R., Barnicoat, A., Pembrey, M. E., Holland, J., Oostra, B. A., Bobrow, M. & Davies, K. E. (1993). Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell. 74, 127-134.
42. Knight, S. J., Ritchie, R. J., Chakrabarti, L., Cross, G., Taylor, G. R., Mueller, R. F., Hurst, J., Paterson, J., Yates, J. R., Dow, D. J. & Davies, K. E. (1996). A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom. Am. J. Hum. Genet. 58, 906-913.
43. Knight, S. J., Voelckel, M. A., Hirst, M. C., Flannery, A. V., Moncla, A., & Davies, K. E. (1994). Triplet repeat expansion at the KRAXE locus and X-linked mild mental handicap. Am. J. Hum. Genet. 55, 81-86.
44. Limprasert, P., Zhong, X., Currie, J. R. & Brown, W. T. (1999). Possible founder effects for FRAXE alleles. Am. J. Med. Genet. 84, 286-290.
45. Longshore, J. W., Tarleton, J. C., Schwartz, C. E., Skinner, C., Skinner, S. A., Schroer, R. J. & Stevenson, R. E. (1997). Trinucleotide repeat expansions in the FMR1 and FMR2 genes are not common etiological factors in autistic children. Am. J. Hum. Genet. Suppl. 61, A106 (592).
46. Lugenbeel, K. A., Peier, A. M., Carson, N. L., Chudley, A. E. & Nelson, D. L. (1996). Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome. Nature Genet. 10, 483-485.
47. Ma, C. & Staudt, L. M. (1996). LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4:11) leukemias. Blood 87, 734-45.
48. Mazzocco, M. M., Myers, G. F., Hamner, J. L., Panoscha, R., Shapiro, B. K., & Reiss, A. L. (1998). The prevalence of the FMR1 and FMR2 mutations among preschool children with language delay. J. Pediatr. 132, 795-801.
49. Mazzocco, M. M., Sonna, X. L., Teisl, J. T., Pinit, A., Shapiro, B. K., Shah, N. & Reiss, A. L. (1997). The FMR1 and FMR2 mutations are not common etiologies of academic difficulty among school-age children. J. Dev. Behav. Pediatr. 18, 392-398.
50. Meadows, K. L., Pettay, D., Newman, J., Hersey, J., Ashley, A. E. & Sherman, S. L. (1996). Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population. Am. J. Med. Genet. 64, 428-433.
51. Merienne, K., Jacquot, S., Pannetier, S., Zeniou, M., Bankier, A., Gecz, J., Mandel, J. L., Mulley, J. C., Sassone-Corsi, P. & Hanaue R. A. (1999). A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nature Genet. 22, 13-14.
52. Mila, M., Sanchez, A., Badenas, C., Brun, C., Jimenez, D., Villa, M. P., Castellvi-Bel, S. & Estivill, X. (1997). Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: identification of a case of FRAXE-associated mental retardation. Hum. Genet. 100, 503-507.
53. Miller, W. J., Skinner, J. A., Foss, G. S. & Davies, K. E. (2000). Localization of the fragile X mental retardation 2 (FMR2) protein in mammalian brain. Eur. J. Neurosci. 12, 381-4.
54. Moore, S. J., Strain, L., Cole, G. F., Miedzybrodzka, Z., Kelly, K. F. & Dean, J. C. (1990). Fragile X syndrome with FMR1 and FMR2 deletion. J. Med. Genet. 36, 565-566.
55. Mulley, J. C., Yu, S., Loesch, D. Z., Hay, D. A., Donnelly, A., Gedeon, A. K., Carbonell, P., Lopez, I., Glover, G., Gabarron, I., Lu, P. W. L., Baker, E., Haan, E. A., Hockey, A., Knight, S. J. L., Davies, K. E., Richards, R. I. & Sutherland, G. R. (1995). FRAXE and mental retardation. J. Med. Genet. 32, 162-169.
56. Murgia, A., Polli, R., Vinanzi, C., Salis, M., Drigo, P., Artifoni, L., & Zacchello, F. (1996). Amplification of the Xq28 FRAXE repeats: extreme phenotype variability ? Am. J. Med. Genet. 64, 441-444.
57. Murray, A., Webb, J., Dennis, N., Conway, G. & Morton, N. (1999). Microdeletions in FMR2 may be a significant cause of premature ovarian failure. J. Med. Genet. 36, 767-770.
58. Murray, A., Webb, J., Grimley, S., Conway, G. & Jacobs, P. (1998). Studies of FRAXA and FRAXE in women with premature ovarian failure. J. Med. Genet. 35, 637-640.
59. Murray, A., Youings, R., Dennis, N., Latsky, L., Linchan, P., McKechnie, N., Macpherson, J., Pound, M. & Jacobs, P. (1996). Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum. Mol. Genet. 5, 727-735.
60. Nelson, D. L., Gu, Y., Yamagata, T., McIlwain, K., Paylor, R. & Zoghbi, H. (1999). A mouse model of FRAXE mental retardation provides detailed study of normal expression and shows behavioral abnormalities. 9th International Workshop on Fragile X Syndrome and X-linked mental retardation, 75.
61. Oostra, B. A. & Willems, P. J. (1998). Murine model of fragile X syndrome, in: Genetic Instabilities and Hereditary Neurological Diseases (ed. R. D. a. W. Wells), pp. 55-61. New York: Academic Press.
62. Parrish, J. E., Oostra, B. A., Verkerk, A., Richards, C. S., Reynolds, J., Spikes, A. S., Shaffer, L. G. & Nelson, D. L. (1994). Isolation of a GCC Repeat Showing Expansion in FRAXF, a Fragile Site Distal to FRAXA and FRAXE. Nature Genet. 8, 229-235.
63. Patsalis, P. C., Sismani, C., Hettinger, J. A., Boumba, I., Georgiou, I., Stylianidou, G., Anastasiadou, V., Koukoulli, H., Pagoulatos, G. & Syrrou, M. (1999). Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability. Am. J. Med. Genet. 84, 184-190.
64. Prasad, R., Yano, T., Sorio, C., Nakamura, T., Rallapalli, R., Gu, Y., Leshkowitz, D., Croce, C. M. & Canaani, E. (1995). Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc. Natl. Acad. Sci. USA. 92, 12160-12164.
65. Richards, R. I., Crawford, J., Narahara, K., Mangelsdorf, M., Friend, K., Staples, A., Denton, M., Easteal, S., Hori, T. A., Kondo, I., Jenkins, T., Goldman, A., Panich, V., Ferakova, E. & Sutherland, G. R. (1996). Dynamic mutation loci: allele distributions in different populations. Ann. Hum. Genet. 60, 391-400.
66. Richards, R. I., Holman, K., Friend, K., Kremer, E., Hillen, D., Staples, A., Brown, W. T., Goonewardena, P., Tarleton, J., Schwartz, C., Sutherland, G. R. (1992). Evidence of founder chromosomes in fragile X syndrome. Nature Genet. 1, 257-260.
67. Ritchie, R. J., Chakrabarti, L., Knight, S. J., Harding, R. M. & Davies, K. E. (1997). Population genetics of the FRAXE and FRAXF GCC repeats, and a novel CGG repeat in Xq28. Am. J. Med. Genet. 73, 463-469.
68. Schwartz, C. K., Dean, J., Howard-Peebles, P. N., Bugge, M., Mikkelsen, M., Tommerup, N., Hull, C., Hagerman, R., Holden, J. J. & Stevenson, R. E. (1994). Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am. J. Med. Genet. 51, 400-402.
69. Sutherland, G. R. & Baker, E. (1992). Characterisation of a new rare fragile site easily confused with the fragile X. Hum. Mol. Genet. 1, 111-113.
70. Sutherland, G. R. & Mulley, J. C. (1996). Fragile X syndrome and fragile XE mental retardation. Prenat. Diagn. 16, 1199-1211.
71. Suthers, G. K., Turner, G. & Mulley, J. C. (1988). A non-syndromal form of X-linked mental retardation (XLMR) is linked to DXS14. Am. J. Med. Genet. 30, 485-491.
72. Taki, T., Kano, H., Taniwaki, M., Sako, M., Yanagisawa, M. & Hayashi, Y. (1999). AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5; 11)(q31 ; q13q23). Proc., Natl. Acad. Sci. USA 96, 14535-14540.
73. Tarleton, J., Richie, R., Schwartz, C., Rao, K., Aylsworth, A. S. & Lachiewicz, A. (1993). An extensive de novo deletion removing FMR1 in a patient with mental retardation and the fragile X syndrome phenotype. Hum. Mol. Genet. 2, 1973-1974.
74. Tassone, F., Hagerman, R. J., Taylor, A. K., Gane, L. W., Godfrey, T. E. & Hagerman, P. J. (2000). Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome. Am. J. Mol. Genet. 66, 6-15.
75. Teague, J. W., Morton, N. E., Dennis, N. R., Curtis, G., McKechnie, N., Macpherson, J. N., Murray, A., Pound, M. C., Sharrock, A. J., Youings, S. A. & Jacobs, P. A. (1998). FRAXA and FRAXE: evidence against segregation distortion and for an effect of intermediate alleles on learning disability. Prof. Natl. Acad. Sci. USA. 95, 719-724.
76. Timms, K. M., Bondeson, M. L., Ansari-Lari, M. A., Lagerstedt, K., Muzny, D. M., Dugan-Rocha, S. P., Nelson, D. L., Pettersson, U. & Gibbs, R. A. (1997). Molecular and phenotypic variation in patients with severe Hunter syndrome. Hum. Mol. Genet. 6, 479-486.
77. Turner, G., Webb, T., Wake, S. & Robinson, H. (1996). Prevalence of fragile X syndrome. Am. J. Med. Genet. 64, 196-197.
78. Van Der Maarel, S. M., Scholten, I. H., Huber, I., Philippe, C., Suijkerbuijk, R. F., Gilgenkrantz, S., Kere, J., Cremers, F. P. & Ropers, H. H. (1996). Cloning and characterization of DXS6673E, a candidate gene for X-linked mental retardation in Xq13.1. Hum. Mol. Genet. 5, 887-897.
79. Verkerk, A. J., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F. & Zhang, F. P. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914.
80. Wang, Q., Green, E., Barnicoat, A., Garrett, D., Mullarkey, M., Bobrow, M. & Mathew, C. G. (1993). Cytogenetic versus DNA diagnosis in routine referrals for fragile X syndrome. Lancet 342, 1025-1026.
81. Weng, G., Bhalla, U. S. & Iyengar, R. (1999). Complexity in biological signaling systems. Science 284, 92-96.
82. Wolff, D. J., Gustashaw, K. M., Zurcher, V., Ko, L., White, W., Weiss, L., Van Dyke, D. L., Schwartz, S. & Willard, H. F. (1997). Deletions in Xq26.3-q27.3 including FMR1 result in a severe phenotype in a male and variable phenotypes in females depending upon the X inactivation pattern. Hum. Genet. 100, 256-261.
83. Zemni, R., Bienvenu, T., Vinet, M. C., Sefiani, A., Carrie, A., Billuart, P., McDonell, N., Couvert, P., Francis, F., Chafey, P., Fauchereau, F., Friocourt, G., Des Portes, V., Cardona, A., Frints, S., Meindl, A., Brandau, O., Ronce, N., Moraine, C., Van Bokhoven, H., Ropers, H. H., Sudbrak, R., Kahn, A., Fryns, J. P., Beldjord, C. & Cheely, J. (2000). A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nature Genet. 24, 167-170.
84. Zhong, X., Ju, W., Curley, D., Wang, D., Pietrofesa, J., Wu, G., Shen, Y., Pang, C., Poon, P., Liu, X., Gou, S., Kajanoja, E., Ryynanen, M., Dobkin, C. & Brown, W. T. (1996). A survey of FRAXE allele sizes in three populations. Am. J. Med. Genet. 64, 415-419.
85. Yntema, H. G., Van Den Helm, B., Kissing, J., Van Duijnhoven, G., Poppelaars, F., Chelly, J., Moraine, C., Fryns, J. P., Hamel, B. C., Heilbronner, H., Pander, H. J., Brunner, H. G., Ropers, H. H., Cremers, F. P. & Van Bokhoven, H. (1999). A novel ribosomal S6-kinase (RSK4: RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. Genomics 62, 332-843.